• Cabazitaxel (XRP6258): Technical Guidance for Resistant Tumo

  2026-06-30

  Cabazitaxel (XRP6258) is a semi-synthetic taxane optimized for disrupting microtubule dynamics in cancer models exhibiting resistance to classic taxanes, including P-glycoprotein-expressing cell lines. It is best applied in DMSO- or ethanol-based assays and is not suitable for water-based systems or long-term solution storage.

• Deficient Endogenous H2S Drives Lipotoxicity in Diabetic Hea

  2026-06-30

  This study uncovers a mechanistic link between reduced endogenous hydrogen sulfide (H2S) production and increased lipotoxicity mediated by endoplasmic reticulum (ER) stress in diabetic cardiomyopathy. The findings suggest that restoring H2S levels can mitigate myocardial injury in diabetes, guiding future research in disease modeling and therapeutic exploration.

• Metal-Ion-Chelating L-Phe Nanostructures Boost Tumor Immunot

  2026-06-29

  This study introduces metal-ion-chelating L-phenylalanine nanostructures that, when combined with short-term starvation, remodel the tumor microenvironment to enhance dendritic cell activation and sensitize breast tumors to immune checkpoint blockade. The findings highlight a mechanistic advance in overcoming immunosuppression in cancer therapy by modulating dendritic cell ion channel activity.

• Docosahexaenoic Acid (DHA): Beyond Neuroprotection to Immune

  2026-06-29

  Explore how Docosahexaenoic Acid (DHA) advances both neuroprotection and immune modulation in research. This article offers a deep dive into DHA’s mechanisms, highlights recent immunological findings, and clarifies practical protocol strategies for translational studies.

• HyperFluor 488 Goat Anti-Human IgG Antibody: Applied Workflo

  2026-06-28

  The HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody empowers sensitive and specific detection across Western blot, immunofluorescence, and flow cytometry, thanks to its robust Alexa Fluor 488 conjugation and precise affinity purification. This article details experimental protocols, troubleshooting, and integrative assay strategies, bridging preclinical innovation with practical immunoassay optimization.

• PPP1R3G/PP1γ Dephosphorylation of RIPK1 Drives Cell Death Pa

  2026-06-27

  This study reveals the essential role of the PPP1R3G/PP1γ phosphatase complex in dephosphorylating RIPK1, thereby activating its kinase function to promote apoptosis and necroptosis. These insights refine our understanding of how inflammatory and cell death signals are regulated at the molecular level, with direct implications for targeted inflammation research.

• ETS1 Regulation of Mitophagy in BPD via the SENP2/HSPA8/FUND

  2026-06-26

  This study identifies ETS1 as a key transcriptional regulator that ameliorates bronchopulmonary dysplasia (BPD) by inhibiting mitochondrial damage-induced autophagy through the SENP2/HSPA8/FUNDC1 axis. The findings provide mechanistic insights into the coordination of mitophagy and lung development, suggesting new molecular targets for BPD intervention.

• hiPSC-Derived Intestinal Organoids Advance Pharmacokinetic M

  2026-06-26

  This study establishes a streamlined protocol for generating human pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) that robustly model intestinal drug metabolism. The approach offers improved scalability and physiological relevance over existing in vitro systems, facilitating more predictive pharmacokinetic studies for orally administered drugs.

• Bispecific Anti-M1R/B6R Antibodies Enhance Orthopoxvirus Pro

  2026-06-25

  This study systematically characterizes monoclonal antibodies targeting the dominant mpox virus immunogens M1R and B6R, mapping their epitopes and functional activities. It introduces a bispecific antibody design with superior broad-spectrum protection against orthopoxviruses, offering a promising strategy for next-generation antibody therapeutics.

• TPCA-1: Precision IKK-2 Inhibitor for Inflammation Research

  2026-06-25

  TPCA-1 is a highly selective IKK-2 inhibitor that empowers researchers to dissect the NF-κB pathway in both in vitro and in vivo models of inflammation. Its robust performance in modulating cytokine production and disease severity, combined with practical solubility and workflow advantages, distinguishes it as a cornerstone for advanced inflammation and rheumatoid arthritis research.

• TPCA-1: Precision IKK-2 Inhibitor Workflows for Inflammation

  2026-06-24

  TPCA-1 stands out as a potent, selective IKK-2 inhibitor, redefining NF-κB pathway modulation in cell and animal models. This article delivers actionable protocols, troubleshooting strategies, and deep insights—empowering researchers to achieve reproducible, high-impact results in inflammation and rheumatoid arthritis studies.

• VER 155008: Applied Workflows for HSP 70 Inhibitor in Cancer

  2026-06-23

  VER 155008, an adenosine-derived HSP 70 inhibitor from APExBIO, empowers apoptosis and proliferation assays with robust specificity and workflow clarity. This article translates complex chaperone inhibition into practical protocols, advanced applications, and actionable troubleshooting strategies for high-impact cancer research.

• Methylprednisolone Sodium Succinate: Molecular Precision in

  2026-06-23

  Explore the advanced molecular mechanisms and translational research value of Methylprednisolone Sodium Succinate, a synthetic corticosteroid with unique apoptosis-inducing and anti-inflammatory properties. This article provides a deeper, methodology-driven perspective for scientists seeking evidence-based insights beyond standard protocols.

• Nicotine Signaling Drives CKD Progression via Renal nAChRs

  2026-06-22

  The reference study systematically reviews the mechanistic links between nicotine exposure and the progression of chronic kidney disease (CKD), highlighting the role of non-neuronal nicotinic acetylcholine receptors (nAChRs) in mediating renal injury. These findings lay groundwork for targeted investigation of signaling pathways that contribute to fibrosis, oxidative stress, and endothelial dysfunction in CKD.

• Streptavidin-HyperFluor 647: Workflow Precision for Biotin D

  2026-06-22

  Streptavidin-HyperFluor™ 647 elevates biotin detection with unmatched sensitivity and low background, empowering advanced proteomic and cell-based assays. This guide unpacks practical protocols, troubleshooting, and innovations that maximize the reagent’s utility in fluorescence microscopy, flow cytometry, and proximity labeling.

16434 records 1/1096 page Next 12345 下5页 Last page